OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Structural perspectives on recent breakthrough efforts toward direct drugging of RAS and acquired resistance
Jameela Lokhandwala, Tracess Smalley, Timothy H. Tran
Frontiers in Oncology (2024) Vol. 14
Open Access | Times Cited: 6
Jameela Lokhandwala, Tracess Smalley, Timothy H. Tran
Frontiers in Oncology (2024) Vol. 14
Open Access | Times Cited: 6
Showing 6 citing articles:
Small molecules for Kirsten rat sarcoma viral oncogene homolog mutant cancers: Past, present, and future
Peiliang Dong, Jiating Ni, Xinyue Zheng, et al.
European Journal of Pharmacology (2025), pp. 177428-177428
Closed Access
Peiliang Dong, Jiating Ni, Xinyue Zheng, et al.
European Journal of Pharmacology (2025), pp. 177428-177428
Closed Access
Thyroid C-Cell Biology and Oncogenic Transformation
Rozita Bagheri‐Yarmand, Elizabeth G. Grubbs, Marie‐Claude Hofmann
Recent results in cancer research/Recent Results in Cancer Research (2025), pp. 51-91
Closed Access
Rozita Bagheri‐Yarmand, Elizabeth G. Grubbs, Marie‐Claude Hofmann
Recent results in cancer research/Recent Results in Cancer Research (2025), pp. 51-91
Closed Access
Targeting KRAS G12D Mutations: Advances in Small Molecule Inhibitors and PROTAC Technology
Robert B. Kargbo
ACS Medicinal Chemistry Letters (2025)
Closed Access
Robert B. Kargbo
ACS Medicinal Chemistry Letters (2025)
Closed Access
Synergistic anti-tumor activity, reduced pERK, and immuno-stimulatory cytokine profiles with 5-FU or ONC212 plus KRAS G12D inhibitor MRTX1133 in CRC and pancreatic cancer cells independent of G12D mutation
Vida Tajiknia, Maximilian Pinho-Schwermann, Praveen Srinivasan, et al.
American Journal of Cancer Research (2024) Vol. 14, Iss. 9, pp. 4523-4536
Closed Access | Times Cited: 3
Vida Tajiknia, Maximilian Pinho-Schwermann, Praveen Srinivasan, et al.
American Journal of Cancer Research (2024) Vol. 14, Iss. 9, pp. 4523-4536
Closed Access | Times Cited: 3
Ringing medicinal chemistry: The importance of 3-membered rings in drug discovery
Sahani Sandalima Uthumange, Angie Jun Hui Liew, Xavier Chee Wezen, et al.
Bioorganic & Medicinal Chemistry (2024) Vol. 116, pp. 117980-117980
Open Access | Times Cited: 2
Sahani Sandalima Uthumange, Angie Jun Hui Liew, Xavier Chee Wezen, et al.
Bioorganic & Medicinal Chemistry (2024) Vol. 116, pp. 117980-117980
Open Access | Times Cited: 2
Advances in Cancer Treatment and Monitoring: Insights from KRAS Inhibitors and Germline Epitope Burden Monitoring
Robert B. Kargbo
ACS Medicinal Chemistry Letters (2024) Vol. 15, Iss. 11, pp. 1815-1817
Open Access
Robert B. Kargbo
ACS Medicinal Chemistry Letters (2024) Vol. 15, Iss. 11, pp. 1815-1817
Open Access
